Search results
Recursion Pharmaceuticals CEO explains how AI could make drug development faster and less costly
CNBC· 2 days agoRecursion Pharmaceuticals is a clinical-stage biotech company that received a $50 million investment...
5 weight-loss drug stocks to watch as Ozempic, Zepbound sales surge
Bankrate via AOL· 4 days agocompany also reported sales growth of 36 percent in 2023. Novo’s market value is now greater than...
Earnings call: Syndax Pharmaceuticals outlines robust Q1 2024 performance By Investing.com
Investing.com· 3 days agoSyndax Pharmaceuticals , Inc. (NASDAQ: NASDAQ:SNDX) has efficiently executed its corporate strategy...
Earnings call: Lexicon Pharmaceuticals Q1 2024 financial results and CEO retirement By Investing.com
Investing.com· 7 days agoLexicon Pharmaceuticals Inc. (NASDAQ:LXRX) reported a net loss of $48.4 million in the first quarter...
2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade
Motley Fool via Yahoo Finance· 13 hours agoVertex Pharmaceuticals Vertex Pharmaceuticals (NASDAQ: VRTX) hasn't been resting on its laurels. The...
Report: State employees health care plan for drugs being overcharged
The Center Square· 17 hours agoNonprofit hospitals can receive deep discounts from pharmaceutical companies for drugs under a...
McKesson misses quarterly estimates as US pharmaceuticals segment weighs
WSAU Wausau· 5 days ago(Reuters) - McKesson Corp reported weaker-than-expected quarterly revenue and profit on Tuesday due to slump in demand for the company's branded and specialty drugs that dragged ...
From Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing -...
Benzinga via Yahoo Finance· 2 days agoPharmaceutical companies have been at the forefront of artificial intelligence for quite some time....
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy | The...
The Motley Fool· 10 hours agoVertex Pharmaceuticals is making steady progress toward earning approval for a new CF medicine. Furthermore, the new therapy was superior in reducing sweat chloride, the presence of which, in high levels, often indicates CF.
Cathie Wood Is Buying This Under-the-Radar AI Stock
Motley Fool via Yahoo Finance· 17 hours agoApril 2, they bought a little over 174 thousand shares of the company, the highest number they have added to ARKG in one swoop this year....